Table 6.
Indication | Appropriate n (%) |
Inappropriate n (%) |
Not assessed n (%) |
---|---|---|---|
Treatment (empiric and targeted) | |||
Febrile neutropenia | 63/199 (31.7%) | 134/199 (67.3%) | 2/199 (1%) |
Gynaecological infection | 0/5 (0%) | 5/5 (100%) | 0/5 (0%) |
Intra-abdominal infection | 183/431 (42.5%) | 243/431 (56.4%) | 5/431 (1.1%) |
Meningitis | 3/8 (37.5%) | 5/8 (62.5%) | 0/8 (0%) |
Osteomyelitis | 17/25 (68%) | 8/25 (32%) | 0/25 (0%) |
Pneumonia | 612/1333 (45.9%) | 703/1333 (52.7%) | 18/1333 (1.4%) |
Sepsis | 873/1248 (70%) | 340/1248 (27.2%) | 35/1248 (2.8%) |
Skin and soft tissue infections | 492/743 (66.2%) | 248/743 (33.4%) | 3/743 (0.4%) |
Urinary tract infection | 539/864 (62.4%) | 312/864 (36.1%) | 13/864 (1.5%) |
aOther | 4/7 (57.1%) | 3/7 (42.9%) | 0/7 (0%) |
Prophylaxis | |||
Surgical prophylaxis | 0/102 (0%) | 102/102 (100%) | 0/102 (0%) |
bOther prophylaxis | 1/40 (2.5%) | 39/40 (97.5%) | 0/40 (0%) |
Other includes endocarditis and acute otitis externa.
Other prophylaxis includes trauma, burn and bite.